ArticleInternational journal of nanomedicine2026
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma.
Ziyun Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.